Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy

Nicole Glodde; Tobias Bald; Debby van den Boorn-Konijnenberg; Kyohei Nakamura; Jake S. O’Donnell; Sabrina Szczepanski; Maria Brandes; Sarah Eickhoff; Indrajit Das; Naveen Shridhar; Daniel Hinze; Meri Rogava; Tetje C. van der Sluis; Janne Ruotsalainen; Evelyn Gaffal; Jennifer Landsberg; Kerstin U. Ludwig; Christoph Wilhelm; Monika Riek‐Burchardt; Andreas J. Müller; Christoffer Gebhardt; Richard A Scolyer; Georgina V. Long; Viktor Janzen; Michele W.L. Teng; Wolfgang Kastenmüller; Massimiliano Mazzone; Mark J. Smyth; Thomas Tüting; Michael Hölzel

doi:10.1016/j.immuni.2017.09.012

Preprint2022

Receptor Tyrosine Kinase Inhibitors in Cancer Immunotherapy

Nasim Ebrahimi, Elmira Fardi, Hajarossadat Ghaderi, Sahar Palizdar, Roya Khorram, Reza Vafadar, Halimeh Mobarak, Amirhossein Ahmadi, Michael R Hamblin, Amir Reza Aref

Article2023

Receptor tyrosine kinase inhibitors in cancer

Nasim Ebrahimi, Elmira Fardi, Hajarossadat Ghaderi, Sahar Palizdar, Roya Khorram, Reza Vafadar, Masoud Ghanaatian, Fatemeh Rezaei‐Tazangi, Payam Baziyar, Amirhossein Ahmadi, Michael R Hamblin, Amir Reza Aref

Article2015

Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer

Andrew J. Gunderson, Megan M. Kaneda, Takahiro Tsujikawa, Abraham V. Nguyen, Nesrine I. Affara, Brian Ruffell, Sara Gorjestani, Shannon M. Liudahl, Morgan Truitt, Peter Olson, Grace Kim, Douglas Hanahan, Margaret A. Tempero, Brett C. Sheppard, Bryan Irving, Betty Chang, Judith A. Varner, Lisa M. Coussens

Preprint2023

Data from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer

Andrew J. Gunderson, Megan M. Kaneda, Takahiro Tsujikawa, Abraham V. Nguyen, Nesrine I. Affara, Brian Ruffell, Sara Gorjestani, Shannon M. Liudahl, Morgan Truitt, Peter Olson, Grace Kim, Douglas Hanahan, Margaret A. Tempero, Brett C. Sheppard, Bryan Irving, Betty Chang, Judith A. Varner, Lisa M. Coussens

Preprint2023

Data from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer

Andrew J. Gunderson, Megan M. Kaneda, Takahiro Tsujikawa, Abraham V. Nguyen, Nesrine I. Affara, Brian Ruffell, Sara Gorjestani, Shannon M. Liudahl, Morgan Truitt, Peter Olson, Grace Kim, Douglas Hanahan, Margaret A. Tempero, Brett C. Sheppard, Bryan Irving, Betty Chang, Judith A. Varner, Lisa M. Coussens

Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy

Discussion(0)

Related publications

Receptor Tyrosine Kinase Inhibitors in Cancer Immunotherapy

Receptor tyrosine kinase inhibitors in cancer

Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer

Data from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer

Data from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer